Search Results - "Sierocki, Pierre"
-
1
ERAP Inhibitors in Autoimmunity and Immuno-Oncology: Medicinal Chemistry Insights
Published in Journal of medicinal chemistry (25-07-2024)“…Endoplasmic reticulum aminopeptidases ERAP1 and 2 are intracellular aminopeptidases that trim antigenic precursors and generate antigens presented by major…”
Get full text
Journal Article -
2
First fragment-based screening identifies new chemotypes inhibiting ERAP1-metalloprotease
Published in European journal of medicinal chemistry (15-12-2024)“…Inhibition of endoplasmic reticulum aminopeptidase 1 (ERAP1) by small-molecules is being eagerly investigated for the treatment of various autoimmune diseases…”
Get full text
Journal Article -
3
Synthesis of novel C -nucleoside analogues bearing an anomeric cyano and a 1,2,3-triazole nucleobase as potential antiviral agents
Published in Organic & biomolecular chemistry (30-03-2022)“…A linear sequence to access a novel series of -nucleosides bearing a quaternary carbon at the anomeric position tethered to a 4-substituted 1,2,3-triazole ring…”
Get more information
Journal Article -
4
Discovery of the First Selective Nanomolar Inhibitors of ERAP2 by Kinetic Target‐Guided Synthesis
Published in Angewandte Chemie International Edition (26-09-2022)“…Endoplasmic reticulum aminopeptidase 2 (ERAP2) is a key enzyme involved in the trimming of antigenic peptides presented by Major Histocompatibility Complex…”
Get full text
Journal Article -
5
-
6
Discovery of the First Selective Nanomolar Inhibitors of ERAP2 by Kinetic Target‐Guided Synthesis
Published in Angewandte Chemie (26-09-2022)“…Endoplasmic reticulum aminopeptidase 2 (ERAP2) is a key enzyme involved in the trimming of antigenic peptides presented by Major Histocompatibility Complex…”
Get full text
Journal Article